Global Hepatitis Treatment and Diagnostics

Kalorama Information
August 1, 2007
200 Pages - SKU: KLI1517677
License type:
Countries covered: Global

The unrecognized importance, danger and costs of hepatitis in the 21st century cannot be understated or underestimated. The impact of the disease on world society is highly significant and now presenting a major crisis in public health circles.

In his exhaustive analysis of the potential diagnosis, screening and therapeutic markets for hepatitis, Ken Krul, PhD. advises companies to think on a global basis. In this study, Global Hepatitis Strategies Krul examines the potential market, epidemiology (hepatitis patient trends) and technology to provide a clear understanding of the opportunities and challenges awaiting companies competing in this market.

As part of the market analysis this report includes

  • Extensive Statistics of Incidence and Prevalence of Hepatitis Across the 6 Major WHO Regions (Americas, Europe, Africa, Western Pacific, Southeast Asia, Eastern Mediterranean)
  • Etiology, Prophylaxis, and Therapy for Hepatitis A, B, C, D and E.
  • Theoretical Revenues for Diagnosis, Screening and Therapeutics representing the potential marketplace if all screening options are pursued.
  • Realistic Market Revenues representing the likely marketplace.
  • Global Distribution of Therapeutics and Diagnostics Revenues across Major 6 WHO regions
  • Over 40 Figures and Tables making information accessible.
Product managers, Marketing executives at pharmaceutical and diagnostic companies; as well as investment professionals are among those who will find this survey a critical resource.


More Global General In Vitro Diagnostics Reports

Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 by GlobalData
Immunochemistry Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 Summary GlobalData’s new report, “Immunochemistry Analyzers and Test Kits - Global ...

2012 Global Yersinia Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
The report presents a detailed analysis of the Yersinia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

2012 Global Vibrio Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country and Market Segment by Venture Planning Group
The report presents a detailed analysis of the Vibrio diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

2012 Global Tuberculosis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

2012 Global Toxoplasmosis Diagnostics Market Outlook: Test Volumes, Sales Forecasts, and Supplier Shares by Country by Venture Planning Group
The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific ...

See all reports like this >>